Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    50,298.59
    +450.62 (+0.90%)
     
  • CMC Crypto 200

    1,389.02
    -7.51 (-0.54%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Global Terminal Sterilization Services Market Report 2024-2034: Innovation, Outsourcing, and Regional Dynamics Driving Industry Growth

Company Logo
Company Logo

Global Terminal Sterilization Services Market

Global Terminal Sterilization Services Market
Global Terminal Sterilization Services Market

Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Global Terminal Sterilization Services Market by Product, by End-User, and By Region" report has been added to ResearchAndMarkets.com's offering.

The comprehensive analysis of the global terminal sterilization services market details its trajectory and projections. Expanding at a steady CAGR of 10.91%, the market's valuation is projected to rise from $12.13 billion in 2023 to a commendable $37.90 billion by the year 2034, based on the latest research. The market's growth is majorly attributed to the rising prevalence of chronic diseases, the need to combat the spread of hospital-acquired infections, and the availability of advanced sterilization technologies.

Market Dynamics and Innovations

Significant developments in the sterilization services segment, particularly in the irradiation method, have propelled its market position. The advanced technology is renowned for its effectiveness and has encouraged partnerships that augment its reach, such as the pivotal one between Sotera Health and E-BEAM Services.

ADVERTISEMENT

End-user Insights

Hospitals and clinics continue to dominate the end-user segment, primarily due to the escalating requirement for sterile instruments and measures to prevent infection. As medical procedures increase, so does the demand for efficient terminal sterilization services. The rollout of novel systems like Cantel Medical Corp.’s STERRAD NX Sterilizer represents the sector's response to the stringent sterility needs.

Geographic Variations and Opportunities

North America maintains its stronghold on the market, with its advanced healthcare framework and rigorous sterilization protocols. Meanwhile, the Asia Pacific region is witnessing rapid growth propelled by healthcare investment surges, enhanced awareness regarding infection control, and burgeoning life sciences sectors.

Terminal Sterilization Services Market Outlook

  • Product Developments: Continuous innovation drives the other methods segment, with a keen eye on sustainable sterilization solutions.

  • End-user Growth: Medical device companies are at the forefront, leveraging outsourcing to meet regulatory specifications.

  • Regional Landscape: The Asia Pacific's swift expansion complements North America's sustained dominance.

The report presents an in-depth study across various regions and covers key countries within those regions, providing industry stakeholders with a detailed understanding of current trends and future market potential. The analysis is supported by comprehensive profiles of leading market participants, underscoring the competitive landscape and the innovative strides shaping the terminal sterilization services market.

Companies Mentioned

  • Steris Corporation

  • Sotera Health

  • Cantel Medical Corp.

  • E-BEAM Services Inc.

  • Cosmed Group Inc.

  • Noxilizer Inc.

  • Beta-Gamma-Service GmbH & Co. KG

  • Sterigenics International LLC

  • Medistri SA

  • Centurion Medical Products Corporation

  • Cretex Companies Inc.

  • Anderson Products Inc.

  • MATACHANA GROUP

  • Pacific BioLabs

  • Avista Pharma Solutions

Key Attributes

Report Attribute

Details

No. of Pages

200

Forecast Period

2023 - 2034

Estimated Market Value (USD) in 2023

$12.13 Billion

Forecasted Market Value (USD) by 2034

$37.9 Billion

Compound Annual Growth Rate

10.9%

Regions Covered

Global

For more information about this report visit https://www.researchandmarkets.com/r/ryq07e

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900